The frequency and somatic mutation landscape of Fibroblast growth factor receptor (FGFR) alterations in breast cancer

被引：2
|
作者：
Giridhar, Karthik V.
Sokol, Ethan S.
Vedell, Peter T.
Sinnwell, Jason P.
Desai, Aakash
Haddad, Tufia C.
O'Sullivan, Ciara C.
Leon-Ferre, Roberto A.
Yadav, Siddhartha
Sideras, Kostandinos
Ernst, Brenda
Liu, Minetta C.
Casey, Abe Eyman
Tang, Xiaojia
Fleischmann, Zoe
Murugesan, Karthikeyan
Kalari, Krishna R.
Goetz, Matthew P.
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P3-08-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-08-02
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis
    Azoury, Said C.
    Reddy, Sashank
    Shukla, Vivek
    Deng, Chu-Xia
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2017, 13 (12): : 1479 - 1488
  • [22] Fibroblast growth factor receptor 3 (FGFR3) mutation in an extensive epidermal naevus
    Collin, B.
    Taylor, I. B.
    Wilkie, A. C. M.
    Moss, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 : 8 - 9
  • [23] Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival
    Tiong, Kai Hung
    Tan, Boon Shing
    Choo, Heng Lungh
    Chung, Felicia Fei-Lei
    Hii, Ling-Wei
    Tan, Si Hoey
    Khor, Nelson Tze Woei
    Wong, Shew Fung
    See, Sze-Jia
    Tan, Yuen-Fen
    Rosli, Rozita
    Cheong, Soon-Keng
    Leong, Chee-Onn
    ONCOTARGET, 2016, 7 (36) : 57633 - 57650
  • [24] Urothelial Bladder Cancer: Genomic Alterations in Fibroblast Growth Factor Receptor
    Maroun Bou Zerdan
    Gennady Bratslavsky
    Joseph Jacob
    Jeffrey Ross
    Richard Huang
    Alina Basnet
    Molecular Diagnosis & Therapy, 2023, 27 : 475 - 485
  • [25] Urothelial Bladder Cancer: Genomic Alterations in Fibroblast Growth Factor Receptor
    Bou Zerdan, Maroun
    Bratslavsky, Gennady
    Jacob, Joseph
    Ross, Jeffrey
    Huang, Richard
    Basnet, Alina
    MOLECULAR DIAGNOSIS & THERAPY, 2023, 27 (04) : 475 - 485
  • [26] Targeting fibroblast growth factor receptor pathway in breast cancer
    Criscitiello, Carmen
    Esposito, Angela
    De Placido, Sabino
    Curigliano, Giuseppe
    CURRENT OPINION IN ONCOLOGY, 2015, 27 (06) : 452 - 456
  • [27] Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor Erdafitinib
    Karkera, Jayaprakash D.
    Cardona, Gabriela Martinez
    Bell, Katherine
    Gaffney, Dana
    Portale, Joseph C.
    Santiago-Walker, Ademi
    Moy, Christopher H.
    King, Peter
    Sharp, Michael
    Bahleda, Rastislav
    Luo, Feng R.
    Alvarez, John D.
    Lorenzi, Matthew V.
    Platero, Suso J.
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (08) : 1717 - 1726
  • [28] Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer
    Giri, D
    Ropiquet, F
    Ittmann, M
    CLINICAL CANCER RESEARCH, 1999, 5 (05) : 1063 - 1071
  • [29] Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer
    Lei, Haipeng
    Deng, Chu-Xia
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2017, 13 (09): : 1163 - 1171
  • [30] Fibroblast Growth Factor Receptor (FGFR) as a Therapeutic Target in Lung and Head and Neck Cancer
    Chae, Young Kwang
    Pai, Sachin G.
    Sun, Peng
    Costa, Ricardo
    Matsangou, Maria
    Agulnik, Mark
    Giles, Francis
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (03) : 13 - 19
12345